In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.
Emerging from stealth, the company is debuting NEXUS, a Large Tabular Model (LTM) designed to treat business data not as a simple sequence of words, but as a complex web of non-linear relationships.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results